Abstract: Against the backdrop of the deepening Healthy China strategy, the integrated innovation and systematic translation of medical devices have become pivotal pathways for enhancing healthcare service capabilities and overcoming critical technological bottlenecks. Addressing current challenges such as fragmented resources, inefficient collaboration, and translational barriers in medical device innovation, this paper establishes an integrated innovation mechanism centered on the deep convergence of "medicine-research-industry-academia-application", and designs a full-cycle systematic translation model spanning "needs identification—R&D validation—regulatory approval—market application". Through strategies including multi-stakeholder collaborative platform development, big-data and AI empowerment, and optimization of policy support systems, efficient allocation of innovation resources and dynamic optimization of translation processes are achieved. Case studies of United Imaging Healthcare and Mindray Medical confirm that integrated innovation significantly shortens R&D cycles and improves translation efficiency, offering a systematic solution to accelerate the domestication of high-end medical devices and strengthen global competitiveness.